Scleroderma renal crisis and concurrent isolated pulmonary hypertension in mixed connective tissue disease and overlap syndrome: Report of two cases

Clinical Rheumatology

Volumn 21, Issue 2, 2002, Pages 164-169

  Andersen, G N ^a   Vasko, J ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Isolated pulmonary hypertension; MCTD; Scleroderma renal crisis; UCTD

Indexed keywords

AMILORIDE; ATENOLOL; AZATHIOPRINE; CAPTOPRIL; CARVEDILOL; CYCLOPHOSPHAMIDE; ENALAPRIL; FUROSEMIDE; METOLAZONE; NIFEDIPINE; PREDNISOLONE; PROSTACYCLIN DERIVATIVE; TORASEMIDE; VERAPAMIL; WARFARIN;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; COMORBIDITY; DEATH; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; KIDNEY DISEASE; LUNG FIBROSIS; MALE; MIXED CONNECTIVE TISSUE DISEASE; PLASMAPHERESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SCLERODERMA; SKIN DISEASE; ACUTE KIDNEY FAILURE; CONNECTIVE TISSUE DISEASE; FATALITY; FOLLOW UP; HOSPITALIZATION; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; RISK ASSESSMENT; SYSTEMIC SCLEROSIS;

ADULT; BIOPSY, NEEDLE; CASE REPORT; CONNECTIVE TISSUE DISEASES; FATAL OUTCOME; FEMALE; FOLLOW-UP STUDIES; HUMAN; HYPERTENSION, PULMONARY; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGE; MIXED CONNECTIVE TISSUE DISEASE; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; HUMANS; MIDDLE AGED;

EID: 0035985716     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-002-8276-5     Document Type: Article

References (21)

1. Mixed connective tissue disease - An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)
2. HLA type as a predictor of mixed connective tissue differentiation. Ten year clinical and immunogenetic followup of 46 patients
3. Is MCTD a distinct entity? Comparison of clinical and laboratory findings in MCTD, SLE, PSS, and RA patients
4. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis
5. Factors predicting development of renal involvement in progressive systemic sclerosis
6. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease
7. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systemic lupus erythematosus and other rheumatic diseases
8. Mixed connective tissue disease: A subsequent evaluation of the original 25 patients
9. Renal involvement in mixed connective tissue disease: A longitudinal clinicopathologic study
10. Pulmonary hypertension in connective tissue disease. Clinical analysis of sixty patients in multi-institutional study
11. Acute scleroderma in stable mixed connective tissue disease: Treatment by plasmaphresis
12. Control of hypertension and reversal of renal failure in undifferentiated connective tissue disease by enalapril
13. Accelerated hypertension in a patient with mixed connective tissue disease
14. Sclerodermatous renal crisis in a patient with mixed connective tissue disease
15. Circulating endothelin-1 levels in systemic sclerosis subsets - A marker of fibrosis or vascular dysfunction
16. HLA type as a predictor of mixed connective tissue disease differentiation. Ten-year clinical and immunogenetic followup of 46 patients
17. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis
18. Increased serum angiotensin I-converting enzyme activity in patients with mixed connective tissue disease and pulmonary hypertension
19. Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis. Findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1 and adhesion molecule 1
20. Long-term outcomes of scleroderma renal crisis
21. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin